digital health funding
The Tampere, Finland-headquartered company now plans to set up operations in the US and Asia.
Leaps by Bayer led the round, bringing the company's total funding to $50 million.
Inne will use the new funding to grow the team ahead of the launch of its product.
Modus Capital led the round with participation from 212 Capital, QSTP, Kasamar Holdings, Dharmendra Ghai, Innoway and other unnamed investors.
The Series B round was led by Greenoaks with participation from Threshold Ventures, CRV, GV and Kleiner Perkins.
The European market is projected to nearly triple its digital health funding from 2018 to 2019.
A new SEC document reveals the company has filed for a total offering of $9.1 million.
Industry players examined the intersection of sex, tech, health and pleasure at the Giant Health event in London last week.
The investment will be used to build a clinical-stage portfolio for rare diseases, including treatments for Fragile X syndrome.
This latest round was led by LBO France with participation from Kurma Diagnostics, Paris Saclay, Idinvest Partners, Seventure and SOSV.